News
Even if children with sickle cell disease appear asymptomatic, it's still crucial to provide proper care, says columnist.
BEAM-101, a genetically modified cell therapy for sickle cell, is designed to turn on HbF to counteract mutated adult ...
For columnist Mary Shaniqua, who tracks her health closely, not being able to discern the causes of a sickle cell crisis is ...
The FDA has granted orphan drug status to rilzabrutinib, an investigational therapy to prevent pain crises in sickle cell ...
Columnist Oluwatosin Adesoye explains why preventing malaria infections is particularly important for those with sickle cell ...
An algorithm is helping to reduce the number of unnecessary hospital admissions for children with sickle cell.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results